Fahima Munir

Fahima Munir has a strong background in finance and accounting with over 20 years of experience. Fahima is currently working as the Senior Director, Controller at Elevar Therapeutics since February 2023. Prior to that, they held the role of Senior Director of Finance at Vestaron Corporation from March 2022 to February 2023, and also served as the Controller at Vestaron Corporation from September 2019 to March 2022. Before that, Fahima worked as a Controller at PeriGen Perinatal Decision Support Systems from April 2018 to September 2019. Fahima also held the position of Accounting Manager at TrialCard from August 2016 to April 2018. Fahima has experience in the pharmaceutical industry, having worked as the Manager of Financial Reporting at Merz Pharmaceuticals from August 2015 to August 2016. Fahima began their career at Salix Pharmaceuticals Inc. in 2006, where they held various roles including Manager of Accounting, Lead Accountant, and Senior Accountant. Fahima also has prior experience in the auditing field, having worked as a Senior Accountant at KPMG LLP from January 2005 to November 2006, and as a Senior Accountant at American Express Tax & Business Svcs from November 1999 to February 2004.

Fahima Munir's education history includes a Bachelor of Science (BS) degree in Accounting from the State University of New York College at Old Westbury. Fahima also holds an Associate of Science (AS) degree in Accounting from Nassau Community College. In addition to their degrees, Fahima Munir has obtained the Certified Public Accountant (CPA) certification.